Qualitative and Quantitative Evaluation of Loose Bodies as a Novel Cell Source for Autologous Chondrocyte Implantation
Open Access
- 20 July 2026
- journal article
- Published by SAGE Publications in Orthopaedic Journal of Sports Medicine
- Vol. 14 (7)
Abstract
Background: Autologous chondrocyte implantation (ACI) has recently produced successful outcomes, but donor site morbidity remains an urgent issue to be resolved. Thus, alternative cell sources are highly desirable to minimize donor site morbidity. Purpose: To qualitatively and quantitatively evaluate the potential of loose bodies as a novel cell source for ACI. Study Design: Controlled laboratory study. Methods: Loose bodies were obtained from 10 patients during arthroscopic surgery. They were evaluated by gross appearance and histology and classified into normal, abnormal, and no-cartilage groups. Then, 3-dimensional (3D)–cultured cartilage was prepared using chondrocytes from the loose bodies, and cell proliferation and glycosaminoglycan production in the 3D-cultured cartilage were compared with those from native cartilage obtained from patients who underwent total knee arthroplasty. Finally, expression of 42 genes by primary chondrocytes from the loose bodies was analyzed by chondrocyte gene spatial mapping analysis (CGSMA) and compared with that of reference chondrocytes to visualize their global properties, including ossification and denaturation. Results: Of 10 loose bodies, 4 were histologically classified into the normal cartilage group, 4 into the abnormal cartilage group, and 2 into the no-cartilage group. The mean cell proliferation rate of 3D-cultured cartilage from the loose bodies in the normal and abnormal cartilage groups was significantly higher than that of the native cartilage ( P = .020), while there was no significant difference in mean glycosaminoglycan production. Scores for the chondrocyte gene spatial mapping analysis showed that the 3D-cultured cartilage produced from 2 loose bodies exhibited gene expression within the reference range of native cartilage. While 2 of the 10 loose bodies (20%) met the predefined criteria across all 3 evaluations, this proportion increased to 50% (2 of 4) when the analysis was restricted to loose bodies classified in the normal cartilage group. Conclusion: A subset of loose bodies demonstrated matrix-producing capacity without ossification or denaturation, supporting their potential as a cell source for ACI. Clinical Relevance: Appropriately selected loose bodies are a potential cell source for ACI while minimizing donor site morbidity.Keywords
Funding Information
- Japan Tissue Engineering Co., Ltd.
This publication has 37 references indexed in Scilit:
- Nutrition, osteoarthritis and cartilage metabolismAging Clinical and Experimental Research, 2019
- Implantation of tissue‐engineered cartilage‐like tissue for the treatment for full‐thickness cartilage defects of the kneeKnee Surgery, Sports Traumatology, Arthroscopy, 2013
- Adipose‐Derived Mesenchymal Stem Cells Exert Antiinflammatory Effects on Chondrocytes and Synoviocytes From Osteoarthritis Patients Through Prostaglandin E2Arthritis & Rheumatism, 2013
- Comparison between normal and loose fragment chondrocytes in proliferation and redifferentiation potentialInternational Orthopaedics, 2012
- Nutrition and degeneration of articular cartilageKnee Surgery, Sports Traumatology, Arthroscopy, 2012
- Atelocollagen-associated autologous chondrocyte implantation for the repair of chondral defects of the knee: a prospective multicenter clinical trial in JapanJournal of Orthopaedic Science, 2009
- Inhibition of interleukin‐1β‐stimulated production of matrix metalloproteinases by hyaluronan via CD44 in human articular cartilageArthritis & Rheumatism, 2004
- Cartilage proteoglycansSeminars in Cell & Developmental Biology, 2001
- The role of the chondrocyte in osteoarthritisArthritis & Rheumatism, 2000
- Human chondrocyte proliferation and matrix synthesis cultured in Atelocollagen gelJournal of Biomedical Materials Research, 2000